Shifa Biomedical

company

About

Shifa Biomedical is a drug discovery company that develops drugs for the treatment of cardiovascular disease.

  • 1 - 10

Details

Last Funding Type
Seed
Industries
Biotechnology,Life Science,Pharmaceutical
Founded date
Jan 1, 2006
Number Of Employee
1 - 10
Operating Status
Active

Shifa Biomedical Corporation is a drug discovery company in Malvern Pennsylvania. It is a privately-held biopharmaceutical company dedicated to the cost-effective development of drugs for the treatment of cardiovascular disease.

Incorporated in 2006, Shifa has recognized expertise for the discovery of small molecule drugs, including pharmaceutical experience guided by biochemical, cell-based, and virtual screening. Shifa scientists exploit molecular biology, biochemistry, crystallography and medicinal, computational, and combinatorial chemistry. Shifa is led by a highly experienced team of scientists with extensive expertise in early-stage drug discovery.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Shifa Biomedical has raised a total of — in funding over 2 rounds. Their latest funding was raised on May 12, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 12, 2021 Seed 1 Xontogeny Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Shifa Biomedical is funded by 1 investors. Xontogeny are the most recent investors.
Investor Name Lead Investor Funding Round
Xontogeny Yes Seed